Post by
Tropicalsun on Aug 04, 2022 10:35am
Let The Dust Settle
Clear your mind, the stock has had a good run, koodo's to those who took profit, it is never a bad thing.
That being said, for those individuals that are long on this company, yesterdays call was good and laid out the path forward. I believe with a few others here that the SP is still under valued and will continue to move higher over time.
I agree with comments from Brooks Oneil that the Sp was down because of the rise in SG and A, I thought both Casey and Todd did a good job to explain all the reason's why. Look the bottom line folks these guys are reinvesting for future growth, it costs money to make money.
The OIG thing widdled down to 1.1 million is a good thing, I for one am pleased that principals matter in this case and like the stand Viemed is taking. Stick that where the sun doesn't shine B2B.
A personal highlite, with the recent news I now believe this company is finally going to start making some acquisitions to help grow the company and add shareholder value.
Lastly, Viemed is becoming more diverse quarter over quater, vent patients are growing rapidly, as Casey mentioned the pier reviewed studies carry tremendous clout. We are seeing evidence of return to historical growth numbers and EBITA margins. There will always be the unkowns that surface from time to time, but I like where this company is heading.
Comment by
Tropicalsun on Aug 04, 2022 10:59am
I forgot to mention that the company has purchased approximately 1.3 million shares under the current NCIB out of the allotted 2 million. So it looks like they are planning to purchase the remainder. All good.
Comment by
69andcounting on Aug 04, 2022 11:14am
I don't comment on this board often but have held the stock for years. Totally agree with you Tropicalsun. To me this report was a classic example of that thing that happens: short-termers react one way, and we long-termers say "all good" and have a drink or two, as I did last evening.